Search: WFRF:(Neven B.)
> (2010-2014) >
CYP2D6 Genotype and...
CYP2D6 Genotype and Adjuvant Tamoxifen : Meta-Analysis of Heterogeneous Study Populations
-
- Province, M. A. (author)
- Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis MO, USA
-
- Goetz, M. P. (author)
- Department of Oncology and Pharmacology, Mayo Clinic, Rochester MN, USA
-
- Brauch, H. (author)
- Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Tübingen University, Tübingen, Germany
-
show more...
-
- Flockhare, D. A. (author)
- Division of Clinical Pharmacology, School of Medicine, Indiana University, Bloomington IN, USA
-
- Hebert, J. M. (author)
- Department of Genetics, School of Medicine, Stanford University, Stanford CA, USA
-
- Whaley, R. (author)
- Department of Genetics, School of Medicine, Stanford University, Stanford CA, USA
-
- Suman, V. J. (author)
- Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester MO, USA
-
- Schroth, W. (author)
- Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; Tübingen University, Tübingen, Germany
-
- Winter, S. (author)
- Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology and University, Tuebingen, Germany
-
- Zembutsu, H. (author)
- Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
-
- Mushiroda, T. (author)
- Laboratory for Pharmacogenetics, RIKEN Center for Genomic Medicine, Yokohama, Japan
-
- Newman, W. G. (author)
- Centre for Genetic Medicine, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
-
- Lee, M-TM. (author)
- Laboratory for International Alliance, RIKEN Center for Genomic Medicine, Yokohama, Japan
-
- Ambrosone, C. B. (author)
- Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo NY, USA
-
- Beckmann, M. W. (author)
- Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
-
- Choi, J-Y (author)
- Department of Biomedical Science, Graduate School, Seoul National University, Seoul, Korea
-
- Dieudonne, A-S (author)
- Department of Oncology, Catholic University Leuven, Leuven, Belgium
-
- Fasching, P. A. (author)
- Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles CA, USA
-
- Ferraldeschi, R. (author)
- Centre for Genetic Medicine, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
-
- Gong, L. (author)
- Department of Genetics, School of Medicine, Stanford University, Stanford CA, USA
-
- Haschke-Becher, E. (author)
- University Institute of Medical and Chemical Laboratory Diagnostics, Paracelsus Private Medical University, Salzburg, Austria
-
- Howel, A. (author)
- The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK
-
- Jordan, L. B. (author)
- Department of Pathology, Ninewells Hospital and Medical School, Dundee, UK
-
- Hamann, U. (author)
- Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum, Heidelberg, Germany
-
- Kiyotani, K. (author)
- Laboratory for Pharmacogenetics, RIKEN Center for Genomic Medicine, Yokohama, Japan
-
- Krippl, P. (author)
- Medical University Graz, Graz, Austria
-
- Lambrechts, D. (author)
- Vesalius Research Center, VIB and Laboratory of Translational Genetics, Department of Oncology, Catholic University Leuven, Leuven, Belgium
-
- Latif, A. (author)
- Centre for Genetic Medicine, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK; Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
-
- Langsenlehner, U. (author)
- Medical University Graz, Graz, Austria
-
- Lorizio, W. (author)
- Division of General Internal Medicine, Department of Medicine and Clinical Pharmacology and Experimental Therapeutics, and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco CA, USA
-
- Neven, P. (author)
- Department of Gynecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium
-
- Nguyen, A. T. (author)
- Division of Clinical Pharmacology, School of Medicine, Indiana University, Bloomington IN, USA
-
- Park, B-W. (author)
- Department of Surgery, Yonsei University Health System, Seoul, Korea
-
- Purdie, C. A. (author)
- Department of Pathology, Ninewells Hospital and Medical School, Dundee, UK
-
- Quinlan, P. (author)
- Dundee Cancer Centre, Dundee, UK
-
- Renner, W. (author)
- Medical University Graz, Graz, Austria
-
- Schmidt, M. (author)
- Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany; University Tübingen, Tübingen, Germany; Department of Gynecology and Obstetrics, University of Mainz, Mainz, Germany
-
- Schwab, M. (author)
- Department of Clinical Pharmacology and Toxicology, University Hospital Tuebingen, Tuebingen, Germany
-
- Shin, J-G (author)
- Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Busan, Korea
-
- Stingl, J. C. (author)
- Division of Research, Federal Institute for Drugs and Medical Devices, University of Bonn Medical Faculty, Bonn, Germany
-
- Wegman, Pia, 1964- (author)
- Örebro universitet,Hälsoakademin
-
- Wingren, Sten, 1950- (author)
- Örebro universitet,Institutionen för läkarutbildning
-
- Wu, A. H. B. (author)
- Department of Laboratory Medicine, University of California, San Francisco CA, USA
-
- Ziv, E. (author)
- Division of General Internal Medicine, Department of Medicine and Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco CA, USA
-
- Zirpoli, G. (author)
- Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo NY, USA
-
- Thompson, A. M. (author)
- Dundee Cancer Centre, Dundee, UK
-
- Jordan, V. C. (author)
- Department of Oncology, Georgetown University, Washington DC, USA
-
- Nakamura, Y. (author)
- Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
-
- Altman, R. B. (author)
- Department of Genetics, School of Medicine, Stanford University, Stanford CA, USA; Department of Bioengineering, Stanford University, Stanford CA, USA
-
- Ames, M. M. (author)
- Department of Pharmacology, Mayo Clinic, Rochester MN, USA
-
- Klein, T. E. (author)
- Department of Genetics, School of Medicine, Stanford University, Stanford CA, USA
-
show less...
-
Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St Louis MO, USA Department of Oncology and Pharmacology, Mayo Clinic, Rochester MN, USA (creator_code:org_t)
- 2013-09-23
- 2014
- English.
-
In: Clinical Pharmacology and Therapeutics. - New York, USA : Nature Publishing Group. - 0009-9236 .- 1532-6535. ; 95:2, s. 216-227
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://europepmc.or...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The International Tamoxifen Pharmacogenomics Consortium was established to address the controversy regarding cytochrome P450 2D6 (CYP2D6) status and clinical outcomes in tamoxifen therapy. We performed a meta-analysis on data from 4,973 tamoxifen-treated patients (12 globally distributed sites). Using strict eligibility requirements (postmenopausal women with estrogen receptor-positive breast cancer, receiving 20 mg/day tamoxifen for 5 years, criterion 1), CYP2D6 poor metabolizer status was associated with poorer invasive disease-free survival (IDFS: hazard ratio = 1.25; 95% confidence interval = 1.06, 1.47; P = 0.009). However, CYP2D6 status was not statistically significant when tamoxifen duration, menopausal status, and annual follow-up were not specified (criterion 2, n = 2,443; P = 0.25) or when no exclusions were applied (criterion 3, n = 4,935; P = 0.38). Although CYP2D6 is a strong predictor of IDFS using strict inclusion criteria, because the results are not robust to inclusion criteria (these were not defined a priori), prospective studies are necessary to fully establish the value of CYP2D6 genotyping in tamoxifen therapy.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Keyword
- Medicine
- Medicin
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Province, M. A.
-
Goetz, M. P.
-
Brauch, H.
-
Flockhare, D. A.
-
Hebert, J. M.
-
Whaley, R.
-
show more...
-
Suman, V. J.
-
Schroth, W.
-
Winter, S.
-
Zembutsu, H.
-
Mushiroda, T.
-
Newman, W. G.
-
Lee, M-TM.
-
Ambrosone, C. B.
-
Beckmann, M. W.
-
Choi, J-Y
-
Dieudonne, A-S
-
Fasching, P. A.
-
Ferraldeschi, R.
-
Gong, L.
-
Haschke-Becher, ...
-
Howel, A.
-
Jordan, L. B.
-
Hamann, U.
-
Kiyotani, K.
-
Krippl, P.
-
Lambrechts, D.
-
Latif, A.
-
Langsenlehner, U ...
-
Lorizio, W.
-
Neven, P.
-
Nguyen, A. T.
-
Park, B-W.
-
Purdie, C. A.
-
Quinlan, P.
-
Renner, W.
-
Schmidt, M.
-
Schwab, M.
-
Shin, J-G
-
Stingl, J. C.
-
Wegman, Pia, 196 ...
-
Wingren, Sten, 1 ...
-
Wu, A. H. B.
-
Ziv, E.
-
Zirpoli, G.
-
Thompson, A. M.
-
Jordan, V. C.
-
Nakamura, Y.
-
Altman, R. B.
-
Ames, M. M.
-
Klein, T. E.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Basic Medicine
-
and Pharmacology and ...
- Articles in the publication
-
Clinical Pharmac ...
- By the university
-
Örebro University